General Information of the Compound
Compound ID
CP0482614
Compound Name
3-[(2-methoxyphenyl)methyl]-2-methyl-7-piperazin-1-ylimidazo[4,5-b]pyridine
    Show/Hide
Structure
Formula
C19H23N5O
Molecular Weight
337.427
Canonical SMILES
COc1ccccc1Cn1c(C)nc2c(ccnc12)N1CCNCC1
    Show/Hide
InChI
InChI=1S/C19H23N5O/c1-14-22-18-16(23-11-9-20-10-12-23)7-8-21-19(18)24(14)13-15-5-3-4-6-17(15)25-2/h3-8,20H,9-13H2,1-2H3
    Show/Hide
InChIKey
AGTXDSXXULSBDI-UHFFFAOYSA-N
Physicochemical Property
logP
2.20622
Rotatable Bonds
4
Heavy Atom Count
25
Polar Areas
55.21
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
6
Complexity
25

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 126720389
ChEMBL ID
CHEMBL4161480
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01354, 5-hydroxytryptamine receptor 6
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 337 nM
   TI
   LI
   LO
   TS